Plakous Therapeutics, Inc.
Biotechnology company · Winston-Salem, North Carolina, United States
Plakous Therapeutics, Inc. is a biotechnology company headquartered in Winston-Salem, North Carolina, United States. Its earliest recorded incorporation is in 2016. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $3.8 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $175,000 sold in a notice filed in 2020.
Plakous Therapeutics at a glance
What does Plakous Therapeutics do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $3.8 million in total (2020 to 2024). NIH funding came from the National Institute of Child Health and Human Development.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $175,000 sold (2020).
Frequently asked questions about Plakous Therapeutics
Where is Plakous Therapeutics headquartered?
Plakous Therapeutics, Inc. is headquartered in Winston-Salem, North Carolina, United States.
What does Plakous Therapeutics do?
Plakous Therapeutics, Inc. is a biotechnology company.
When was Plakous Therapeutics founded?
The earliest incorporation on record for Plakous Therapeutics, Inc. is in 2016, according to public company registers.
Similar companies
- Tengion IncWinston-Salem, North Carolina, United States
- Prokidney Corp.Winston-Salem, North Carolina, United States
- Precise Bio, Inc.Winston-Salem, North Carolina, United States
- Biographics, Inc.Winston-Salem, North Carolina, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences